title: Seroepidemiology of new AIDS-associated adenoviruses among the San Francisco Men's Health Study.
abstract: A seroprevalence survey to recently proposed adenovirus (AV) serotypes AV 48 and AV 49, isolated primarily from AIDS patients, was conducted among the San Francisco Men's Health Study cohort. This cohort of homosexual, heterosexual, or bisexual HIV-seronegative and -seropositive men from selected San Francisco census tracts has been studied since 1984. The presence or absence of type-specific antibody in 628 serum specimens from 1989 was determined by microneutralization. Thirty of these subjects (26 positive and four negative) were studied longitudinally. Serum specimens taken at 6-month intervals from 1984 to 1993 were tested to characterize antibody response and to document the advent of these new serotypes. Eight subjects were tested against five other AV serotypes for comparison. AV 48 and AV 49 seroprevalence rates were significantly higher in HIV-seropositives, but infection was not limited to the immunocompromised. Sexual preference was not a significant determinant for AV seroprevalence in HIV-seronegatives. However, the extent and duration of the neutralizing antibody response was strikingly different between homosexuals and heterosexuals: an endemic pattern of continuous reexposure over the 9-year period was seen in 90% of 19 homosexuals, while five of six heterosexuals (83%) had an episodic pattern of exposure with antibody decline to undetectable levels. These data suggest that these viruses may be endemic in some part of the homosexual population and that sexual transmission may be the primary source of continuous reexposure.
authors.affiliation: Viral and Rickettsial Disease Laboratory, California Department of Health Services, Berkeley 94704, USA.
authors.forename: L
authors.initials: L
authors.lastname: Crawford-Miksza
authors.forename: D P
authors.initials: DP
authors.lastname: Schnurr
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000097:blood / Q000276:immunology / Q000821:virology*; D000257:Adenoviridae Infections / Q000453:epidemiology / Q000276:immunology / Q000821:virology*; D000260:Adenoviruses, Human / Q000276:immunology / Q000302:isolation & purification*; D000328:Adult; D015331:Cohort Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009500:Neutralization Tests; D012495:San Francisco / Q000453:epidemiology